Strategic Initiative
Slingshot members are tracking this corporate initiative:
Entellus Medical Acquires XeroGel from CogENT Therapeutics, Strengthens Product Portfolio
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ENTL |
|
|
CogENT Therapeutics |
|
|
Additional Information
“We are pleased to secure ownership of this best-in-class nasal dressing technology as well as solidify control of the supply chain and distribution to our physician customers. We are excited about the opportunity to leverage our world class engineering team to explore potential innovations and future Research and Development projects,” said Robert White, President and Chief Executive Officer of Entellus Medical. “This acquisition highlights our continued commitment to the ENT space and our efforts to provide products that deliver an optimal physician and patient experience.”
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jun 29, 2016 Projected Implementation: Q2, 2016 Relevance Tracked Until: Q3, 2016
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Xerogel